Name | Laprituximab |
---|
Description | Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289[1]. |
---|---|
Related Catalog | |
In Vivo | 在 H292 异种移植瘤模型中,Laprituximab (J2898A) 的最低有效剂量为 3 mg/kg[1]。 |
References |
No Any Chemical & Physical Properties |